Local erythematous dermatitis after intravenous docetaxel

Gynecologic and Obstetric Investigation

Volumn 53, Issue 2, 2002, Pages 118-120

  Hirai, Kouzo ^a   Ishiko, Osamu ^a   Nakajima, Satoko ^a   Kanaoka, Yasushi ^a   Nakamura, Yoshihiro ^a   Oiso, Naoki ^a   Ishii, Masamitsu ^a   Ogita, Sachio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adverse effect; Chemotherapy; Docetaxel; Erythema multiforme

Indexed keywords

DOCETAXEL;

AGED; ARTICLE; CASE REPORT; DERMATITIS; DISEASE COURSE; ERYTHEMA MULTIFORME; FEMALE; HISTOLOGY; HUMAN; INFUSION; PRIORITY JOURNAL; RASH; SKIN DEFECT; TIME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ERUPTIONS; ERYTHEMA MULTIFORME; FEMALE; FIREARMS; HUMANS; INFUSIONS, INTRAVENOUS; OVARIAN NEOPLASMS; PACLITAXEL; TAXOIDS;

EID: 0036230337     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053006     Document Type: Article

References (5)

1. Taxol: A novel investigational antimicrotubule agent
2. Supravenous discoloration of the skin due to docetaxel treatment
3. Skin reactions to 5-fluorouracil
4. Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bro-modeoxyuridine) therapy and radiotherapy
5. Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment